🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

State Street SPDR S&P Biotech ETF

XBI
$163.81 $-0.573 (-0.35%)
Market Cap: $11.47 B
Gurus Holding
6
Popularity Rank
#1360
% of Shares Held
2.95%
Net Activity (Q3 2026)
-$95.99 M

Guru Ownership Trend

Guru Analysis for State Street SPDR S&P Biotech ETF (XBI)

State Street SPDR S&P Biotech ETF (XBI), a key player in the Market sector, continues to attract institutional attention.

As of Q3 2026, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $336.75 M.

Top institutional holders include Jefferies Group and Paul Tudor Jones.

Institutional sentiment is currently Bearish. This is evidenced by a $95.99 M net outflow during the quarter.

Recent activity highlights Renaissance Technologies (RenTech) who opened a new position. Conversely, Paul Tudor Jones reduced exposure by 31.9%.

Key Holders

Recent Activity Breakdown (Q3 2026)

+$4.72 M
Total Buy Value
New Buys 3
Additions 0
-$100.71 M
Total Sell Value
Reductions 3
Sold Out 1

Guru Consensus (Q3 2026)

Based on recent activity
Net Sellers
4
Net Buyers
3

FAQs for State Street SPDR S&P Biotech ETF (XBI)

Major holders include Jefferies Group ($262.14 M), Paul Tudor Jones ($53.95 M), Renaissance Technologies (RenTech) ($3.77 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 2.06 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $95.99 M, with 3 managers increasing positions and 4 managers reducing holdings.

During the most recent reporting period, 3 managers trimmed their positions, while 1 fully exited XBI. The total reported sell value was $100.71 M.

Yes, 3 managers opened new positions in XBI, and 0 increased their existing holdings. The total reported buy value was $4.72 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
1.94% Reduce -22.3% 1,662,500 $262.14 M Q3 2026
0.07% Reduce -31.9% 342,117 $53.95 M Q3 2026
0.01% New Buy 23,900 $3.77 M Q3 2026
0.00% Reduce -5.5% 21,191 $3.34 M Q3 2026
0.00% New Buy 4,617 $728,009 Q3 2026
0.00% New Buy 1,412 $222,711 Q3 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form